Imposter in the brain: aetiological, clinical and neuroimaging characteristics of Capgras syndrome
Brain · 07.04.2026 · 149 (4) · 1224-1238
DOI: 10.1093/brain/awaf378 ↗Kurz gefasst
Fachartikel in der Zeitschrift Brain, online erschienen am 08.10.2025. Verfasst von Hiroyuki Watanabe und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Mayo Clinic, Rochester, MN 55905, USA. Hauptthemen laut MEDLINE: Capgras Syndrome, Brain. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 100 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIH HHS, Japan Society for the Promotion of Science, NIA NIH HHS.
Abstract (Originalsprache)
Capgras syndrome is a delusional misidentification syndrome characterized by the recurrent belief that someone, usually a family member, has been replaced by an impostor. Although described over a century ago, its aetiology, clinical features and neuroimaging characteristics remain poorly understood due to its rarity. This study aimed to clarify these aspects through the analysis of a large cohort and to explore its clinical implications and underlying mechanisms. We conducted a retrospective cohort study by reviewing medical records of patients diagnosed with Capgras syndrome at the Mayo Clinic (Rochester, MN) over a 28-year period (January 1995 to December 2022). Clinical, neuropathological and neuroimaging data were analysed. A total of 204 patients were included (median age at onset: 73 years; 44% female). Twelve patients underwent neuropathological examination, all of whom exhibited α-synuclein pathology, including one patient with a clinical diagnosis of Alzheimer’s disease (AD). Regarding clinical diagnoses, neurodegenerative diseases were the most common (69%, n = 140), with dementia with Lewy bodies (DLB) being predominant (58%, n = 118), followed by mixed aetiologies (‘two-hits’) (18%, n = 36) and AD (10%, n = 21). Psychotic disorders accounted for 9% (n = 18) of cases. No case was attributed to a single stroke, although 9% (n = 19) involved coexisting cerebrovascular disease in the context of AD or DLB. In DLB, the timing of Capgras syndrome onset varied: it occurred later than cognitive decline and core clinical features (e.g. visual hallucinations, fluctuating cognition, parkinsonism) in both DLB and mild cognitive impairment-onset prodromal DLB, but earlier in psychiatric-onset prodromal DLB. In both DLB and AD, Capgras syndrome typically targeted a single spouse, whereas in psychotic disorders, it often involved multiple, non-spousal targets. Depression or anxiety was present in 55% (n = 112). Capgras syndrome worsened in the evening or at night (87%, n = 45/52), suggesting a link to negative affective states. Among 82 patients with DLB and AD treated with cholinesterase inhibitors, 15% (n = 12) showed symptomatic improvement. Neuroimaging with MRI and 18F-fluorodeoxyglucose-PET revealed widespread bilateral cortical involvement and prominent right frontal dysfunction in DLB and AD. Capgras syndrome is associated with DLB and could serve as a potential early diagnostic clue. Recognizing its phenomenological features—the number and type of targeted individuals—can help differentiate between neurodegenerative and psychiatric aetiologies. In neurodegenerative diseases, Capgras syndrome may reflect a multifactorial, dynamic process, driven by widespread bilateral cortical dysfunction (particularly involving the right frontal lobe) and psychological factors. Thus, a combined approach involving pharmacological and non-pharmacological interventions may offer effective management strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Neurology, Mayo Clinic, Rochester, MN 55905, USA.
- Department of Radiology, Mayo Clinic, Rochester, MN 55905, USA.
ORCID-Profile: Hiroyuki Watanabe, Jennifer L Whitwell, Keith A Josephs
Förderung
- NIH HHS
- Japan Society for the Promotion of Science
- NIA NIH HHS
- NIDCD NIH HHS
- Mayo Clinic
- NINDS NIH HHS
- National Institutes of Health
Zitieren
APA
Watanabe, H., Whitwell, J. L., Bhaskaran, J. G., Lowe, V. J., & Josephs, K. A. (2026). Imposter in the brain: aetiological, clinical and neuroimaging characteristics of Capgras syndrome. Brain, 149(4), 1224-1238. https://doi.org/10.1093/brain/awaf378
Vancouver
Watanabe H, Whitwell JL, Bhaskaran JG, Lowe VJ, Josephs KA. Imposter in the brain: aetiological, clinical and neuroimaging characteristics of Capgras syndrome. Brain. 2026;149(4):1224-1238. doi:10.1093/brain/awaf378
BibTeX
@article{Watanabe2026,
author = {Watanabe, Hiroyuki and Whitwell, Jennifer L and Bhaskaran, Jerusha G and Lowe, Val J and Josephs, Keith A},
title = {Imposter in the brain: aetiological, clinical and neuroimaging characteristics of Capgras syndrome},
journal = {Brain},
year = {2026},
volume = {149},
number = {4},
pages = {1224--1238},
doi = {10.1093/brain/awaf378}
}
EUVIMED